SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-21-000187
Filing Date
2021-05-17
Accepted
2021-05-17 15:14:52
Documents
28
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl0514form10q.htm 10-Q 162048
2 EXHIBIT 31.1 cncl0514form10qexh31_1.htm EX-31.1 8094
3 EXHIBIT 31.2 cncl0514form10qexh31_2.htm EX-31.2 8108
4 EXHIBIT 32.1 cncl0514form10qexh32_1.htm EX-32.1 3939
  Complete submission text file 0001554795-21-000187.txt   756151

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cncl-20210331.xml EX-101.INS 38588
6 XBRL SCHEMA FILE cncl-20210331.xsd EX-101.SCH 8412
7 XBRL CALCULATION FILE cncl-20210331_cal.xml EX-101.CAL 17978
8 XBRL DEFINITION FILE cncl-20210331_def.xml EX-101.DEF 10317
9 XBRL LABEL FILE cncl-20210331_lab.xml EX-101.LAB 76859
10 XBRL PRESENTATION FILE cncl-20210331_pre.xml EX-101.PRE 55715
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 21929777
SIC: 6770 Blank Checks